Hanseatic Management Services Inc Intercept Pharmaceuticals, Inc. Transaction History

Hanseatic Management Services Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $3,433 - $5,948	274 New	274 $4,000
Q1 2020 Apr 22, 2020	SELL	$48.35 - $118.68 $4,496 - $11,037	-93 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$57.36 - $124.1 $5,334 - $11,541	93 New	93 $12,000
Q2 2019 Jul 19, 2019	SELL	$77.77 - $120.68 $161,528 - $250,652	-2,077 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$91.83 - $120.68 $20,569 - $27,032	224 Added 12.09%	2,077 $232,000

Q4 2018 Jan 29, 2019	SELL	$85.79 - $126.46 $18,187 - $26,809	-212 Reduced 10.27%	1,853 $187,000
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $182,731 - $263,390	2,065 New	2,065 $261,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.